SCHEMBL4159878

SCHEMBL4159878

O=C(N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NCc1csc(-c2ccccc2)n1)c1cn[nH]c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.45
ROCK1 Q13464 1/20 0.45
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CTSV O60911 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
DNM1L O00429 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
MME P08473 1/20 0.36
RHOC P08134 1/20 0.36
RHOA P61586 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4149913 0.84 SMN1; SMN2 (0.43) ROCK2ROCK1HPGDNPC1RAB9A
SCHEMBL4166182 0.84 PADI4 (0.48) ROCK2ROCK1HPGDNPC1RAB9A
SCHEMBL4174440 0.81 SHMT1 (0.41) HPGDNPC1RAB9AHDAC1HDAC2
SCHEMBL27715265 0.79 ROCK2 (0.49) ROCK2ROCK1HPGDNPC1RAB9A
SCHEMBL5129796 0.79 ROCK2 (0.49) ROCK2ROCK1HPGDNPC1RAB9A
SCHEMBL4159882 0.79 HDAC1 (0.36) ROCK2ROCK1NPC1RAB9AHDAC1
SCHEMBL4160443 0.77 KDM4E (0.39) HPGDNPC1RAB9AHDAC1HDAC2
SCHEMBL4166897 0.76 PADI4 (0.41) ROCK2ROCK1HDAC1HDAC2
SCHEMBL4166894 0.76 KDM4E (0.43) HPGDHDAC1HDAC2LMNAKDM4E
SCHEMBL4156142 0.75 ROCK2 (0.38) ROCK2HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 ROCK2 2524/4885ROCK1 1497/4885HPGD 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.